CA1136138A - Cephalosporin analogs and methods for production thereof - Google Patents

Cephalosporin analogs and methods for production thereof

Info

Publication number
CA1136138A
CA1136138A CA000342597A CA342597A CA1136138A CA 1136138 A CA1136138 A CA 1136138A CA 000342597 A CA000342597 A CA 000342597A CA 342597 A CA342597 A CA 342597A CA 1136138 A CA1136138 A CA 1136138A
Authority
CA
Canada
Prior art keywords
group
carbon atoms
compound
process according
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000342597A
Other languages
English (en)
French (fr)
Inventor
Tadashi Hirata
Ikuo Matsukuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of CA1136138A publication Critical patent/CA1136138A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA000342597A 1978-12-26 1979-12-21 Cephalosporin analogs and methods for production thereof Expired CA1136138A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53162008A JPS6058920B2 (ja) 1978-12-26 1978-12-26 セフアロスポリン類縁体
JP162,008/78 1978-12-26

Publications (1)

Publication Number Publication Date
CA1136138A true CA1136138A (en) 1982-11-23

Family

ID=15746283

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000342597A Expired CA1136138A (en) 1978-12-26 1979-12-21 Cephalosporin analogs and methods for production thereof

Country Status (9)

Country Link
JP (1) JPS6058920B2 (de)
CA (1) CA1136138A (de)
CH (1) CH642968A5 (de)
DE (1) DE2952413C2 (de)
DK (1) DK549479A (de)
FR (1) FR2445327A1 (de)
GB (1) GB2041923B (de)
IT (1) IT1192795B (de)
NO (1) NO794177L (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof
JPS63184229U (de) * 1987-05-19 1988-11-28
US4885291A (en) * 1988-01-14 1989-12-05 Eli Lilly And Company 1-carba(dethia)-3-cephem derivatives
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents
CA2067708A1 (en) * 1991-05-10 1992-11-11 Richard A. Berglund Process for preparing doubly blocked 1-carba(1-dethia)-3-cephem-4-carboxylic acids
DE4331391A1 (de) * 1993-09-15 1995-03-16 Josef Dr Kemmer Halbleiter(detektor)struktur
WO2004037163A2 (en) * 2002-05-14 2004-05-06 Northwestern University STERICALLY-AWKWARD β-LACTAMASE INHIBITORS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPS6058920B2 (ja) 1985-12-23
FR2445327A1 (fr) 1980-07-25
NO794177L (no) 1980-06-27
DE2952413C2 (de) 1986-12-11
JPS5587791A (en) 1980-07-02
DE2952413A1 (de) 1980-07-17
GB2041923A (en) 1980-09-17
CH642968A5 (de) 1984-05-15
DK549479A (da) 1980-06-27
GB2041923B (en) 1983-07-20
IT1192795B (it) 1988-05-04
FR2445327B1 (de) 1983-05-06
IT7969476A0 (it) 1979-12-24

Similar Documents

Publication Publication Date Title
US4342760A (en) Cephalosporin analogues
CA1136138A (en) Cephalosporin analogs and methods for production thereof
IE55402B1 (en) Process for the manufacture of 1-sulfo-2-oxoazetidine derivatives
US5804577A (en) Cephalosporin derivatives
EP0043546B1 (de) 7-Oxo-cephalosporine und 6-Oxo-penicilline, ihre Analoge und Verfahren zu ihrer Herstellung
HU195664B (en) Process for producing cepheme derivatives and pharmaceutical compositions containing them
EP0154417A2 (de) 7-Amino-3-substituierte Methyl-3-Cephem-4-carboxylsäure und seine niedrigen Alkylsilyl-Derivate und seine Herstellung
CA1109859A (en) Thiooxime cephalosporin and penicillin derivatives
GB2173798A (en) Cephalosporanic acid derivatives
IE43845B1 (en) 4-thia-1-azabicyclo/4.2.0/oct-2-ene derivatives
EP0018546B1 (de) Verfahren zur Herstellung von Phenylglycyl-chlorid-hydrochloriden
Yanagisawa et al. Synthesis of 7α-substituted cephalosporins. V Novel oxidation procedure for syntheses of 7α-methoxycephalosporins and 6α-methoxypenicillins
EP0907654B1 (de) Verfahren zur de-esterifikation
JPH0321544B2 (de)
EP0117872B1 (de) Herstellungsverfahren von cephalosporinverbindungen
EP0091576B1 (de) 7-Oxo-4-thia-1-azabicyclo(3,2,0)Heptan-Derivate
KR960006800B1 (ko) 카르바페넴을 위한 알케닐실릴아제티디논 중간체
US4304909A (en) Process for producing 7-(D(-)-α-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-α-(4-hydroxyphenyl)acetamido)-3-(5-(1-methyl-1,2,3,4-tetrazolyl)thiomethyl)-.DELTA.3 -cephem-4-carboxylic acid and a pharmaceutically acceptable salt thereof
JP2602669B2 (ja) ２β−ハロゲノ置換メチルペニシリン誘導体の製造法
US5922861A (en) De-esterification process
EP0117875B1 (de) Verfahren zur herstellung von azetidinonabkömmlingen
GB1602876A (en) Method for producing cepham compounds
HU195222B (en) Process for production of pename-, cefem- and cefamsulphons
KR100228189B1 (ko) 씨-3 위치가 치환된 세펨 유도체의 제조방법 ii
EP0010667B1 (de) Cepham-Verbindungen, sie enthaltende pharmazeutische Zusammensetzungen, Verfahren zu deren Herstellung sowie zur Herstellung bekannter Cephem-Verbindungen

Legal Events

Date Code Title Description
MKEX Expiry